BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 9747431)

  • 1. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin AT1 receptor inhibition, angiotensin-converting enzyme inhibition, and combination therapy with developing heart failure: cellular mechanisms of action.
    Spinale FG; Iannini JP; Mukherjee R; Melton DM; de Gasparo M
    J Card Fail; 1998 Dec; 4(4):325-32. PubMed ID: 9924854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine monotherapy, angiotensin-converting enzyme inhibition, and combination therapy with pacing-induced heart failure.
    Kribbs SB; Merritt WM; Clair MJ; Krombach RS; Houck WV; Dodd MG; Mukherjee R; Spinale FG
    Hypertension; 1998 Mar; 31(3):755-65. PubMed ID: 9495258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance.
    New RB; Sampson AC; King MK; Hendrick JW; Clair MJ; McElmurray JH; Mandel J; Mukherjee R; de Gasparo M; Spinale FG
    Circulation; 2000 Sep; 102(12):1447-53. PubMed ID: 10993866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
    Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
    Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failure.
    Multani MM; Krombach RS; Goldberg AT; King MK; Hendrick JW; Sample JA; Baicu SC; Joffs C; deGasparo M; Spinale FG
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):369-76. PubMed ID: 11907639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.
    Spinale FG; Holzgrefe HH; Mukherjee R; Webb ML; Hird RB; Cavallo MJ; Powell JR; Koster WH
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1082-94. PubMed ID: 9399980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin AT1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition.
    Clair MJ; Krombach RS; Coker ML; Heslin TL; Kribbs SB; de Gasparo M; Spinale FG
    J Mol Cell Cardiol; 1998 Nov; 30(11):2355-64. PubMed ID: 9925371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term angiotensin-converting enzyme and angiotensin I--receptor inhibition in pacing-induced heart failure: effects on myocardial interstitial bradykinin levels.
    Multani MM; Krombach RS; Hendrick JW; Baicu SC; Joffs C; Sample JA; deGasparo M; Spinale FG
    J Card Fail; 2001 Dec; 7(4):348-54. PubMed ID: 11782859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain blood flow patterns after the development of congestive heart failure: effects of treadmill exercise.
    Caparas SN; Clair MJ; Krombach RS; Hendrick JW; Houck WV; Kribbs SB; Mukherjee R; Tempel GE; Spinale FG
    Crit Care Med; 2000 Jan; 28(1):209-14. PubMed ID: 10667524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.
    Funabiki K; Onishi K; Dohi K; Koji T; Imanaka-Yoshida K; Ito M; Wada H; Isaka N; Nobori T; Nakano T
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2487-92. PubMed ID: 15548724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.
    McElmurray JH; Mukherjee R; New RB; Sampson AC; King MK; Hendrick JW; Goldberg A; Peterson TJ; Hallak H; Zile MR; Spinale FG
    J Pharmacol Exp Ther; 1999 Nov; 291(2):799-811. PubMed ID: 10525103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure.
    Shannon RP; Friedrich S; Mathier M; Knight DR
    Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure.
    Spinale FG; Johnson WS; Wang Y; Wang Z; Mukherjee R; Hebbar L; Jones BU
    J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.